ARIPIPRAZOLE

Post-LOESM

aripiprazole

Hetero

ANDAORALTABLET

Approved

Apr 2015

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

ARIPIPRAZOLE (aripiprazole) by Hetero is unknown. Approved for schizophrenia. First approved in 2015.

Drug data last refreshed 21h ago

Mechanism of Action

unknown. However, the efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D 2 and 5-HT 1A receptors and antagonist activity at 5-HT 2A receptors. Actions at receptors other than D 2 , 5-HT 1A , and 5-HT 2A may explain some of the other clinical effects of…

Pharmacologic Class:

Atypical Antipsychotic

Indications (1)

Schizophrenia

Clinical Trials (20)

NCT06589817Phase 3Not Yet Recruiting

A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia

Started Oct 2024

376 enrolled

Acute Schizophrenia

NCT04907279N/AUnknown

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)

Started Nov 2021

200 enrolled

SchizophreniaSchizo Affective DisorderBipolar I Disorder

NCT04203056Phase 4Terminated

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Started Dec 2019

15 enrolled

SchizophreniaSchizoaffective Disorder, Depressive TypeSchizophreniform Disorder

NCT04030143Phase 1/2Completed

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Started Aug 2019

266 enrolled

SchizophreniaBipolar I Disorder

NCT03881449Phase 4Unknown

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole

Started Apr 2019

46 enrolled

SchizophreniaMajor Depressive DisorderBi-Polar Disorder+1 more

Worked on ARIPIPRAZOLE at Hetero? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.